Tumors often contain areas of oxygen-deficient tissue that frequently withstand conventional therapies. This is because the ...

Volume of distribution at steady state (L/kg) 187 194 194 Table 2. Changes in cough-related symptoms following treatment with levocloperastine 30, 60 and 120 mg/day for 6 days in patients with ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...

Most importantly, pharmacological agents that can inhibit early organ ... whether vitamin B12 displayed protective and ...

Researchers explore the mechanisms, therapeutic potential, and clinical applications of curcumin in preventing and treating ...

suggesting potential therapeutic effect Positive trend observed in seven out of eight IPF biomarkers in Cohort 2, with four ...

“Fortunately, the therapeutic landscape has changed dramatically in recent ... are frequently more effective and better ...

In a recent article, researchers synthesized and characterized amino acid-functionalized magnetite nanoparticles, exploring ...

The pharmacokinetic behaviour of levocloperastine observed in animal studies has been confirmed in human studies. The pharmacokinetics of levocloperastine and racemic DL-cloperastine were ...